292 related articles for article (PubMed ID: 21812966)
1. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type.
Krust B; El Khoury D; Nondier I; Soundaramourty C; Hovanessian AG
BMC Cancer; 2011 Aug; 11():333. PubMed ID: 21812966
[TBL] [Abstract][Full Text] [Related]
2. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
El Khoury D; Destouches D; Lengagne R; Krust B; Hamma-Kourbali Y; Garcette M; Niro S; Kato M; Briand JP; Courty J; Hovanessian AG; Prévost-Blondel A
BMC Cancer; 2010 Jun; 10():325. PubMed ID: 20573279
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.
Destouches D; El Khoury D; Hamma-Kourbali Y; Krust B; Albanese P; Katsoris P; Guichard G; Briand JP; Courty J; Hovanessian AG
PLoS One; 2008 Jun; 3(6):e2518. PubMed ID: 18560571
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin.
Krust B; El Khoury D; Soundaramourty C; Nondier I; Hovanessian AG
Biochimie; 2011 Mar; 93(3):426-33. PubMed ID: 21040752
[TBL] [Abstract][Full Text] [Related]
5. Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L.
Birmpas C; Briand JP; Courty J; Katsoris P
BMC Cell Biol; 2012 Nov; 13():32. PubMed ID: 23146273
[TBL] [Abstract][Full Text] [Related]
6. Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.
Fujiki H; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2014 May; 140(5):689-99. PubMed ID: 24469254
[TBL] [Abstract][Full Text] [Related]
7. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells.
Nisole S; Said EA; Mische C; Prevost MC; Krust B; Bouvet P; Bianco A; Briand JP; Hovanessian AG
J Biol Chem; 2002 Jun; 277(23):20877-86. PubMed ID: 11919179
[TBL] [Abstract][Full Text] [Related]
8. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells.
Legrand D; Vigié K; Said EA; Elass E; Masson M; Slomianny MC; Carpentier M; Briand JP; Mazurier J; Hovanessian AG
Eur J Biochem; 2004 Jan; 271(2):303-17. PubMed ID: 14717698
[TBL] [Abstract][Full Text] [Related]
9. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans.
Nisole S; Krust B; Callebaut C; Guichard G; Muller S; Briand JP; Hovanessian AG
J Biol Chem; 1999 Sep; 274(39):27875-84. PubMed ID: 10488134
[TBL] [Abstract][Full Text] [Related]
10. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor.
Said EA; Krust B; Nisole S; Svab J; Briand JP; Hovanessian AG
J Biol Chem; 2002 Oct; 277(40):37492-502. PubMed ID: 12147681
[TBL] [Abstract][Full Text] [Related]
11. Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release.
Destouches D; Huet E; Sader M; Frechault S; Carpentier G; Ayoul F; Briand JP; Menashi S; Courty J
J Biol Chem; 2012 Dec; 287(52):43685-93. PubMed ID: 23109338
[TBL] [Abstract][Full Text] [Related]
12. A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu.
Barel M; Hovanessian AG; Meibom K; Briand JP; Dupuis M; Charbit A
BMC Microbiol; 2008 Sep; 8():145. PubMed ID: 18789156
[TBL] [Abstract][Full Text] [Related]
13. The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells.
Losfeld ME; Khoury DE; Mariot P; Carpentier M; Krust B; Briand JP; Mazurier J; Hovanessian AG; Legrand D
Exp Cell Res; 2009 Jan; 315(2):357-69. PubMed ID: 19026635
[TBL] [Abstract][Full Text] [Related]
14. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin.
Hovanessian AG
Cell Res; 2006 Feb; 16(2):174-81. PubMed ID: 16474431
[TBL] [Abstract][Full Text] [Related]
15. Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.
Goldshmit Y; Trangle SS; Kloog Y; Pinkas-Kramarski R
Oncotarget; 2014 Sep; 5(18):8602-13. PubMed ID: 25261371
[TBL] [Abstract][Full Text] [Related]
16. Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.
Wise JF; Berkova Z; Mathur R; Zhu H; Braun FK; Tao RH; Sabichi AL; Ao X; Maeng H; Samaniego F
Blood; 2013 Jun; 121(23):4729-39. PubMed ID: 23599269
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin down-regulation is involved in ADP-induced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells.
Wang W; Luo J; Xiang F; Liu X; Jiang M; Liao L; Hu J
PLoS One; 2014; 9(10):e110101. PubMed ID: 25290311
[TBL] [Abstract][Full Text] [Related]
18. Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death.
Schokoroy S; Juster D; Kloog Y; Pinkas-Kramarski R
PLoS One; 2013; 8(9):e75269. PubMed ID: 24086490
[TBL] [Abstract][Full Text] [Related]
19. Targeting nucleolin for better survival in diffuse large B-cell lymphoma.
Jain N; Zhu H; Khashab T; Ye Q; George B; Mathur R; Singh RK; Berkova Z; Wise JF; Braun FK; Wang X; Patel K; Xu-Monette ZY; Courty J; Young KH; Sehgal L; Samaniego F
Leukemia; 2018 Mar; 32(3):663-674. PubMed ID: 28690315
[TBL] [Abstract][Full Text] [Related]
20. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
